John Snisarenko, Chief Commercial Officer at Oyster Point Pharma, Inc. (OYST), bought 4,000 shares at $25.97 ($104K) on 2020-08-10, disclosed to the SEC on 2020-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |